03 - Navigating the Future of Pharmacy Benefit Costs: Trends, GLP-1, and Gene Therapy

This session will feature an in-depth analysis of pharmacy cost pressures with a focus on the impact of GLP-1 and Gene Therapy.

Speakers:

Donna C. Novak

NovaRest Actuarial Consulting

Kali Schweitzer PharmD

Milliman Inc.

Mr. Ron Ogborne

Mercer

Ms. Sarah Suzanne Hellems

Optum Pharmacy Advisory Services

Credits:

CPD Credit: 1.50